PAIN Vector Science and Therapeutics Corp.
Vector Science and Therapeutics Corp. develops precision biomechanical devices and active transdermal delivery systems for musculoskeletal regeneration. The company offers cGMP-manufactured Rx peptides for physicians and patients across sports, regenerative, and longevity medicine channels. It also provides VectorMist, a commercial precision therapeutic platform, as well as Valor, a delivery system and transdermal platform. The company is based in Mequon, Wisconsin.…
Industry Peers
Medical DevicesKey Statistics
About Vector Science and Therapeutics (CVE: PAIN)
›
Vector Science and Therapeutics (CVE: PAIN) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.
The shares were at 2.530 CAD on 19 November 2026. Its 52-week range is 0.3500 CAD to 3.230 CAD: the price is 21.7% below the high and 622.9% above the low.
Its market capitalisation is 13.91M CAD.
Vector Science and Therapeutics reports return on equity of -52.1% and an operating margin of 0.0%.
It holds more cash than debt, a net cash position of 1.17M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.